The Goa's Health Ministry on August 7 received 1,008 vials of Remdesivir from pharma major Cipla. Remdesivir is an anti-viral drug that is administered to COVID-19 patients and results in faster recovery, the state Health Minister said.
For our comprehensive coverage and latest updates on COVID-19 click here.
"This anti-viral drug will be beneficial in suppressing the viral replication of SARS-CoV-2, the coronavirus that causes COVID-19. Uncontrollable viral replication is often responsible for tissue damage and deaths in patients infected with the virus," he said in a statement. The minister also said that the anti-viral drug will be administered to moderately and severely-ill patients suffering from COVID-19 and would help to suppress the viral replication of SARS-CoV-2. "The drug will help in faster recovery of COVID-19 patients. Introduction of Remdesivir in the COVID-19 treatment protocol will also help us reduce COVID-19 deaths associated with co-morbidity," he said. Goa is currently witnessing a sustained spike in the number of COVID-19 cases. The state has recorded 7,614 coronavirus cases in all, out of which 2,095 are active. 66 people have died after contracting the deadly infection.